Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
10.41
+0.29 (2.87%)
At close: Aug 13, 2025, 4:00 PM
10.65
+0.24 (2.31%)
After-hours: Aug 13, 2025, 7:55 PM EDT
Viatris Market Cap
Viatris has a market cap or net worth of $12.14 billion as of August 13, 2025. Its market cap has decreased by -15.62% in one year.
Market Cap
12.14B
Enterprise Value
26.09B
1-Year Change
-15.62%
Ranking
n/a
Category
Stock Price
$10.41
Market Cap Chart
Since December 1, 1998, Viatris's market cap has increased from $4.38B to $12.14B, an increase of 177.04%. That is a compound annual growth rate of 3.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 12, 2025 | 11.80B | -20.60% |
Dec 31, 2024 | 14.86B | 14.38% |
Dec 29, 2023 | 12.99B | -3.74% |
Dec 30, 2022 | 13.50B | -17.51% |
Dec 31, 2021 | 16.36B | 61.24% |
Dec 31, 2020 | 10.15B | -2.18% |
Dec 31, 2019 | 10.37B | -26.57% |
Dec 31, 2018 | 14.13B | -37.75% |
Dec 29, 2017 | 22.70B | 11.18% |
Dec 30, 2016 | 20.41B | -23.22% |
Dec 31, 2015 | 26.59B | 26.03% |
Dec 31, 2014 | 21.10B | 26.97% |
Dec 31, 2013 | 16.62B | 48.53% |
Dec 31, 2012 | 11.19B | 22.22% |
Dec 30, 2011 | 9.15B | 39.85% |
Dec 31, 2010 | 6.54B | 16.21% |
Dec 31, 2009 | 5.63B | 86.89% |
Dec 31, 2008 | 3.01B | -13.89% |
Dec 31, 2007 | 3.50B | -17.30% |
Dec 29, 2006 | 4.23B | -1.54% |
Dec 30, 2005 | 4.30B | -9.67% |
Dec 31, 2004 | 4.76B | -29.94% |
Dec 31, 2003 | 6.79B | 58.86% |
Dec 31, 2002 | 4.27B | -9.23% |
Dec 31, 2001 | 4.71B | 49.79% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 574.04B |
Johnson & Johnson | 416.11B |
AbbVie | 350.91B |
UnitedHealth Group | 236.90B |
Novartis AG | 230.64B |
Abbott Laboratories | 228.03B |
Novo Nordisk | 223.00B |
Merck & Co. | 200.57B |